These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 18780640)

  • 1. [T cell immune response during HIV infection and immune escape].
    Wan YM; Chou C; Zhang XY; Xu JQ
    Bing Du Xue Bao; 2008 Jul; 24(4):326-33. PubMed ID: 18780640
    [No Abstract]   [Full Text] [Related]  

  • 2. T cells versus HIV-1: fighting exhaustion as well as escape.
    Robinson HL
    Nat Immunol; 2003 Jan; 4(1):12-3. PubMed ID: 12496971
    [No Abstract]   [Full Text] [Related]  

  • 3. Rates of HIV immune escape and reversion: implications for vaccination.
    Davenport MP; Loh L; Petravic J; Kent SJ
    Trends Microbiol; 2008 Dec; 16(12):561-6. PubMed ID: 18964018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversal of T-cell exhaustion as a strategy to improve immune control of HIV-1.
    Bui JK; Mellors JW
    AIDS; 2015 Sep; 29(15):1911-5. PubMed ID: 26355569
    [No Abstract]   [Full Text] [Related]  

  • 5. De novo generation of escape variant-specific CD8+ T-cell responses following cytotoxic T-lymphocyte escape in chronic human immunodeficiency virus type 1 infection.
    Allen TM; Yu XG; Kalife ET; Reyor LL; Lichterfeld M; John M; Cheng M; Allgaier RL; Mui S; Frahm N; Alter G; Brown NV; Johnston MN; Rosenberg ES; Mallal SA; Brander C; Walker BD; Altfeld M
    J Virol; 2005 Oct; 79(20):12952-60. PubMed ID: 16188997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversion of immune escape HIV variants upon transmission: insights into effective viral immunity.
    Kent SJ; Fernandez CS; Dale CJ; Davenport MP
    Trends Microbiol; 2005 Jun; 13(6):243-6. PubMed ID: 15936652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of T cell immunity in HIV-1 infection.
    Munier CM; Kelleher AD; Kent SJ; De Rose R
    Curr Opin Virol; 2013 Aug; 3(4):438-46. PubMed ID: 23747036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measuring HIV-1-specific T cell immunity: how valid are current assays?
    D'Souza MP; Altfeld M
    J Infect Dis; 2008 Feb; 197(3):337-9. PubMed ID: 18184092
    [No Abstract]   [Full Text] [Related]  

  • 9. HIV infection: where have all the T cells gone?
    Rowland-Jones S
    Lancet; 1999 Jul; 354(9172):5-7. PubMed ID: 10406356
    [No Abstract]   [Full Text] [Related]  

  • 10. Limited efficiency of endogenous interleukin-7 levels in T cell reconstitution during HIV-1 infection: will exogenous interleukin-7 therapy work?
    Rethi B; Vivar N; Sammicheli S; Chiodi F
    AIDS; 2009 Apr; 23(7):745-55. PubMed ID: 19318908
    [No Abstract]   [Full Text] [Related]  

  • 11. Escape of human immunodeficiency virus from immune control.
    McMichael AJ; Phillips RE
    Annu Rev Immunol; 1997; 15():271-96. PubMed ID: 9143689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective escape from CD8+ T-cell responses represents a major driving force of human immunodeficiency virus type 1 (HIV-1) sequence diversity and reveals constraints on HIV-1 evolution.
    Allen TM; Altfeld M; Geer SC; Kalife ET; Moore C; O'sullivan KM; Desouza I; Feeney ME; Eldridge RL; Maier EL; Kaufmann DE; Lahaie MP; Reyor L; Tanzi G; Johnston MN; Brander C; Draenert R; Rockstroh JK; Jessen H; Rosenberg ES; Mallal SA; Walker BD
    J Virol; 2005 Nov; 79(21):13239-49. PubMed ID: 16227247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increasingly successful highly active antiretroviral therapy delays the emergence of new HLA class I-associated escape mutations in HIV-1.
    Knapp DJ; Brumme ZL; Huang SY; Wynhoven B; Dong WW; Mo T; Harrigan PR; Brumme CJ
    Clin Infect Dis; 2012 Jun; 54(11):1652-9. PubMed ID: 22460975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [[Research Progress in Escape Mutations of the Human Immunodeficiency Virus under Pressure of HLA-Restricted Cytotoxic T Lymphocytes].
    Shi Y; Wan Y; Xu J
    Bing Du Xue Bao; 2015 May; 31(3):299-306. PubMed ID: 26470538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple HIV-1 infection of cells and the evolutionary dynamics of cytotoxic T lymphocyte escape mutants.
    Wodarz D; Levy DN
    Evolution; 2009 Sep; 63(9):2326-39. PubMed ID: 19486149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Making sense of the HIV immune response.
    Goepfert PA
    Top HIV Med; 2003; 11(1):4-8. PubMed ID: 12717044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unique acquisition of cytotoxic T-lymphocyte escape mutants in infant human immunodeficiency virus type 1 infection.
    Pillay T; Zhang HT; Drijfhout JW; Robinson N; Brown H; Khan M; Moodley J; Adhikari M; Pfafferott K; Feeney ME; St John A; Holmes EC; Coovadia HM; Klenerman P; Goulder PJ; Phillips RE
    J Virol; 2005 Sep; 79(18):12100-5. PubMed ID: 16140787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune escape precedes breakthrough human immunodeficiency virus type 1 viremia and broadening of the cytotoxic T-lymphocyte response in an HLA-B27-positive long-term-nonprogressing child.
    Feeney ME; Tang Y; Roosevelt KA; Leslie AJ; McIntosh K; Karthas N; Walker BD; Goulder PJ
    J Virol; 2004 Aug; 78(16):8927-30. PubMed ID: 15280502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular and molecular interactions in HIV infections: a review.
    Tumbo-Oeri AG; Omwandho CA
    East Afr Med J; 2002 May; 79(5):249-53. PubMed ID: 12638808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impairment of B-cell functions during HIV-1 infection.
    Amu S; Ruffin N; Rethi B; Chiodi F
    AIDS; 2013 Sep; 27(15):2323-34. PubMed ID: 23595152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.